Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Lang, Hauke
ALPPS for Colorectal Liver MetastasesJOURNAL OF GASTROINTESTINAL SURGERY. Bd. 21. H. 1. 2017 S. 190-192
Makris, Georgios-Marios; Marinelis, Alexandros; Battista, Marco-Johannes et al.
An ovarian mass after breast cancer: Metachronous carcinoma or metastasis? A case reportINTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. Bd. 31. 2017 S. 106-108
Fasching, Peter A.; Grischke, Eva -Maria; Schuetz, Florian et al.
Analysis of everolimus starting dose as prognostic marker in HR plus mBC patients treated with everolimus (EVE) plus exemestane (EXE): Results of the 3rd interim analysis of the non-interventional trial BRAWO.JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Junginger, Theodor; Goenner, Ursula; Hitzler, Mirjam et al.
Analysis of local recurrences after transanal endoscopic microsurgery for low risk rectal carcinomaINTERNATIONAL JOURNAL OF COLORECTAL DISEASE. Bd. 32. H. 2. 2017 S. 265-271
Imre, Gergely; Berthelet, Jean; Heering, Jan et al.
Apoptosis inhibitor 5 is an endogenous inhibitor of caspase-2EMBO REPORTS. Bd. 18. H. 5. 2017 S. 733-744
Nguyen-Tat, Marc; Rodeck, Jens; Galle, Peter
APPS-Project - The Future Model Patient as a PartnerGASTROENTEROLOGE. Bd. 12. H. 3. 2017 S. 267-267
Frees, Sebastian; Kamal, Mohammed; Nestler, Sebastian et al.
ARE THE CURRENT FOLLOW-UP GUIDELINES AFTER TREATMENT FOR ORGAN CONFINED RENAL CANCER SUFFICIENT?JOURNAL OF UROLOGY. Bd. 197. H. 4. 2017 S. E914-E914
Stueber, Tanja; Novopashenny, Igor; Diessner, Joachim et al.
Are There Breast Cancer Patients with Node-Negative Small Tumours, Who Do Not Benefit from Adjuvant Systemic Therapy?ONCOLOGY. Bd. 92. H. 6. 2017 S. 317-324
Moebus, Volker; Hell, Susanne; Schmidt, Marcus
Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast CancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 77. H. 10. 2017 S. 1079-1087
Jewell, Roxanne C.; Kipps, Thomas J.; Duerig, Jan et al.
Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapyLEUKEMIA & LYMPHOMA. Bd. 58. H. 2. 2017 S. 348-356